Evaluation of the Effect of Selenium Consumption on the Immune System in Patients with non-Hodgkin Lymphoma

Phase 3

• Conditions: non-Hodgkin's lymphoma patients with DLBCL subtype.; Diffuse large B-cell lymphoma; C83.3

• Registration Number: IRCT20191023045208N1
• Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 17 December 2019

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Patients with Non-Hodgkin Lymphoma with Diffuse Large B-cell Lymphoma (DLBCL) Subtype
Patient being in remission phase

Exclusion Criteria

Patients with non-Hodgkin lymphoma with other disease subtype than diffuse large B-cell lymphoma (DLBCL)
Patient being in active phase of the disease

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Changes in the frequency of Th1 lymphocytes after 3 months of selenium consumption. Timepoint: At the beginning of the study and 3 months later. Method of measurement: Flow cytometry test.;Changes in the frequency of Th2 lymphocytes after 3 months of selenium consumption. Timepoint: At the beginning of the study and 3 months later. Method of measurement: Flow cytometry test.;Changes in the frequency of Th17 lymphocytes after 3 months of selenium consumption. Timepoint: At the beginning of the study and 3 months later. Method of measurement: Flow cytometry test.